PCI Pharma Services

BPO/Outsource Services · Philadelphia, PA · Founded 1991 · Privately Held (backing)

Provider of pharmaceutical contract development and manufacturing services intended to serve pharmaceutical and biotechnology companies worldwide. PCI Pharma Services is based in Philadelphia, PA and was founded in 1991. Its last reported valuation was $10 billion in Jul 2025. It has raised $1.5 billion across 1 recorded round; the latest was a private secondary transaction in Jul 2025.

Last reported valuation
$10.0B
Oct 2026
Priced at
—
Total raised
$1.5B
Last round
Secondary Transaction - Private
Jul 2025

PCI Pharma Services key facts

as of Oct 2026
  • Provider of pharmaceutical contract development and manufacturing services intended to serve pharmaceutical and biotechnology companies worldwide.
  • PCI Pharma Services is valued at approximately $10.0B as of Oct 2026 (last reported valuation).
  • It has raised $1.5B across 1 recorded rounds; the latest was Secondary Transaction - Private in Jul 2025.
  • Notable investors include Mubadala Investment Company, Blue Owl Capital, Bain Capital, Alberta Investment Management, Kohlberg & Company — 8 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$10.0B

PCI Pharma Services's last reported valuation, Jul 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of PCI Pharma Services with a free account
  • ·Watch PCI Pharma Services: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

PCI Pharma Services funding rounds

1 rounds
Jul 2025Secondary Transaction - Private—▮

PCI Pharma Services valuation

PCI Pharma Services's last reported valuation was $10 billion in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has PCI Pharma Services raised?

PCI Pharma Services has raised $1.5 billion in total; 1 of its rounds is on record. The most recent was a private secondary transaction in Jul 2025.

PCI Pharma Services investors

8 investors are on record for PCI Pharma Services, including Mubadala Investment Company, Blue Owl Capital, Bain Capital and Alberta Investment Management. The private secondary transaction in Jul 2025 drew 3 investors.

About PCI Pharma Services

Provider of pharmaceutical contract development and manufacturing services intended to serve pharmaceutical and biotechnology companies worldwide. The company specializes in drug development support, clinical trial supply, contract drug manufacturing, sterile and non-sterile drug product packaging, and global pharmaceutical logistics, thereby enabling clients with coordinated and compliant support across the drug development and commercialization process.

Industry
BPO/Outsource Services
Sector
Business Products and Services (B2B)
HQ
Philadelphia, PA, United States
Founded
1991
Employees
7,500
Website
pci.com/
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.